A TECHNO-ECONOMIC NEWS MAGAZINE FOR MEDICAL PLASTICS AND PHARMACEUTICAL INDUSTRY
Our 12th Year of Publication
Page  1  of 2

Manufacturing


Validation of Sterilization Process

Mr Sanjay Shah
Unikal Consultants
QUALITY MANAGEMENT SYSTEM: ISO 9001 & ISO 13485; CE, USFDA 510k,
WHO-GMP & TECHNOLOGY CONSULTANTS

Validation is a documented procedure for obtaining, recording, and interpreting the results needed to show that a process will consistently yield a product complying with predetermined specifications. This article includes explanations, definitions and procedures related to effective validation with special reference to Ethylene Oxide Sterilization.

PURPOSE
The purpose of the validation of sterilization process is to provide objective evidence that a process consistently produces a result that meets specification. It is performed by establishing equipment parameters as per required settings or conditions.
 

Definitions

Validation - Objective evidence that a process consistently produces a result that meets specification. Performed by setting equipment at different settings or conditions
Validation protocol - how each individual process validation will be completed

Validation is a documented procedure for obtaining, recording, and interpreting the results needed to show that a process will consistently yield a product complying with predetermined specifications.

INPUT DOCUMENTS
FMEA, Product specification, Equipment / software qualifications, Historical validations, Processes, Component characterization, Process characterization (Design of Experiments)

REQUIREMENTS
Document controlled processes
Trained operators / assemblers
Calibrated equipment and gauges
Traceable / accepted components
Clearly documented test results

FACTORS TO CONSIDER
FMEA Type
Validation scope
Critical process inputs
Process output and specification
Critical process parameters and ranges

FIRST STEP IN PROCESS
The effectiveness of any sterilization process is dependent upon the amount of bioburden on the item. Bioburden is defined as the number of microorganisms on a contaminated object. Bioburden adversely affects the sterilization process in four basic ways:
1)     Some organisms have hard shells surrounding them which makes them difficult to penetrate
2)     the number of microorganisms may be in excess of the amount of sterilant required to kill them
3)     the amount and type of soil may act as a shield to protect the organism
4)     device may have cracks and crevices in which microorganisms hide

ETHYLENE OXIDE
EtO gas has been the predominate choice for low temperature sterilization since the 1960s. EtO has excellent product penetration and material compatibility. EtO is an alkylating agent, increases the pH greater than 7, which reacts with the DNA of the microorganism and destroys the cells’ ability to metabolize or reproduce.

To design an effective validation and routine control program for a sterilization process, the bioburden on the product and packaging must be considered.

Bioburden is defined as “the population of viable microorganisms on a product and/or a package” and is characterized in terms of number, identity, and resistance. A validated test method must demonstrate that it can consistently and adequately remove the bioburden from the product and packaging.

Microbial death relating to the gaseous sterilization of healthcare products is an exponential function typically defined as the probability of a nonsterile item existing per a given number of units in a batch.

This probability, called the sterility assurance level (SAL), defines the “probability of a viable microorganism being present on a product unit after sterilization.”

While sterilization can reduce the bioburden on a given product to a very low number, that probability can never be reduced to zero.

Therefore, in order to achieve the desired bioburden levels, it is critical to design a validation program that provides a high degree of confidence for consistent sterilization.


Page 2
Back | Back to Top |Next